KINASET THERAPEUTICS
Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.
KINASET THERAPEUTICS
Industry:
Health Care Medical Therapeutics
Founded:
2020-01-01
Address:
Medfield, Massachusetts, United States
Country:
United States
Total Employee:
251+
Status:
Active
Contact:
(508) 858-5810
Total Funding:
41.5 M USD
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Gimv
Gimv investment in Series A - Kinaset Therapeutics
Atlas Venture
Atlas Venture investment in Series A - Kinaset Therapeutics
5AM Ventures
5AM Ventures investment in Series A - Kinaset Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-07 | Kinaset Therapeutics Appoints Christopher O’Brien, MD, PhD, FCCP, as Chief Medical Officer |
More informations about "Kinaset Therapeutics"
About Us - Kinaset Therapeutics
Kinaset Therapeutics is focused on developing inhaled therapeutics to address significant unmet medical needs in respiratory diseases. Our lead clinical candidate, KN-002, is a novel and non-invasive anti-inflammatory to treat all …See details»
Kinaset Therapeutics - Crunchbase Company Profile
Nov 6, 2020 Organization. Kinaset Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Kinaset Therapeutics is a therapeutics company that focuses on the …See details»
Kinaset Therapeutics Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Kinaset Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Kinaset Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 30, 2020: Series A - …See details»
Kinaset Therapeutics to Share Outcomes from the Phase 1 Clinical ...
Sep 4, 2024 The United States Adopted Name (USAN) Council in consultation with the World Health Organization (WHO)’s International Non-proprietary Names (INN) Expert Committee, …See details»
Kinaset Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kinaset Therapeutics, Inc. of Medfield, MA. Get the latest business insights from Dun & Bradstreet.See details»
Gimv is founding investor of Kinaset Therapeutics in a USD 40m …
Nov 30, 2020 management team and board of directors with strong backgrounds in the development of respiratory therapeutics. Bram Vanparys, Partner at Gimv, commented: “I am …See details»
Kinaset Therapeutics - Overview, News & Similar companies
May 14, 2023 Kinaset Therapeutics Announces Dosing Underway in its Phase 1b Study of KN-002 in Healthy Volunteers and Asthma Patients BOSTON--(BUSINESS WIRE)--Kinaset …See details»
Kinaset Therapeutics - Contacts, Employees, Board Members
Organization. Kinaset Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Contacts 2. …See details»
Kinaset Therapeutics to Share Outcomes from the Phase 1 Clinical ...
BOSTON, September 04, 2024--Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious respiratory diseases, today …See details»
11-30-13-Kinaset Tx Launches with a 40m Series A financing — …
MEDFIELD, MA, November 30, 2020 (GLOBE NEWSWIRE) — Kinaset Therapeutics, Inc. (“Kinaset” or the “Company”), a newly-founded biopharmaceutical company, today announced …See details»
Developing a Novel Anti-Inflammatory for Patients with Severe …
Robert Clarke, Ph.D., CEO of Kinaset Therapeutics, discusses Kinaset's novel approach to developing inhaled therapeutics for respiratory diseases and the candidate advancing through …See details»
Kinaset Therapeutics debuts with $40M for pan-JAK asthma med
Nov 30, 2020 Theravance Biopharma, like Kinaset, is working on a pan-JAK inhibitor, while Roche's Genentech is developing a JAK1 inhibitor. RELATED: Eleusis sheds light on …See details»
Science — Kinaset Therapeutics
Kinaset is developing inhaled therapeutics to address significant unmet medical needs in respiratory diseases, with an initial focus on severe asthma. Globally 1.5-2 million people live …See details»
Kinaset Therapeutics Launches with a $40M Series A ... - Business …
Nov 30, 2020 Kinaset Therapeutics, Inc. (“Kinaset” or the “Company”), a newly-founded biopharmaceutical company, today announced a $40 million Series A financing w. ... 5 World …See details»
Kinaset Therapeutics Launches With $40 Million Series A to …
Nov 30, 2020 Biotechnology startup Kinaset Therapeutics Inc. has launched with $40 million in venture financing to develop a drug that could make life easier for people with severe asthma.See details»
News - Kinaset Therapeutics
11.30.20 - Kinaset Therapeutics Launches with a $40M Series A Financing to Develop Novel Therapeutics for Respiratory Diseases and an Exclusive Global License Agreement with …See details»
Kinaset developing dry powder inhalation therapy for severe asthma
Nov 22, 2022 Closely-held Kinaset Therapeutics is developing a less invasive and potentially more cost-effective dry power inhalation alternative to currently approved injectable biologicals …See details»
Bio-Christopher-O'Brien — Kinaset Therapeutics
Christopher O’Brien, MD, PhD, FCCP Chief Medical Officer. Chris joined Kinaset in June 2022 bringing over 20 years of early and late phase clinical development experience leading …See details»